Johnson & Johnson

General ticker "JNJ" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $372.0B (TTM average)

Johnson & Johnson follows the US Stock Market performance with the rate: 4.0%.

Estimated limits based on current volatility of 2.8%: low 145.00$, high 153.35$

Factors to consider:

  • Earnings expected soon, date: 2025-04-15 bmo
  • Company included in S&P500 list
  • Company pays dividends (quarterly): last record date 2025-02-18, amount 1.24$ (Y3.29%)
  • US accounted for 61.0% of revenue in the fiscal year ended 2023-01-01
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-29 to 2026-12-29

  • 2024-12-29 to 2025-12-29 estimated range: [116.08$, 167.69$]
  • 2025-12-29 to 2026-12-29 estimated range: [113.00$, 165.82$]

Financial Metrics affecting the JNJ estimates:

  • Positive: Non-GAAP EPS, $ of 9.99 > 2.18
  • Negative: Industry operating cash flow per share per price (median), % of -12.61 <= 2.91
  • Negative: negative Industry operating income (median)
  • Positive: Industry inventory ratio change (median), % of -0.67 <= -0.27
  • Positive: Inventory ratio change, % of 0.68 <= 1.09
  • Positive: Return on assets ratio (scaled to [-100,100]) of 7.24 > 6.86

Similar symbols

Short-term JNJ quotes

2025-02-272025-02-282025-03-032025-03-042025-03-052025-03-062025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-09140145150155160165170
Price $

Long-term JNJ plot with estimates

120140160180200220240Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 20260123
JNJS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2023-01-01 2023-12-31 2024-12-29
Operating Revenue $79,670.00MM $85,159.00MM $88,821.00MM
Operating Expenses $60,311.00MM $61,750.00MM $66,672.00MM
Operating Income $19,359.00MM $23,409.00MM $22,149.00MM
Non-Operating Income $0.00MM $-8,347.00MM $-5,462.00MM
Interest Expense $276.00MM $772.00MM $755.00MM
R&D Expense $14,918.00MM $15,085.00MM $17,232.00MM
Income(Loss) $19,359.00MM $15,062.00MM $16,687.00MM
Taxes $2,989.00MM $1,736.00MM $2,621.00MM
Other Income(Loss) $1,571.00MM $21,827.00MM $0.00MM
Profit(Loss)* $19,512.00MM $56,980.00MM $14,066.00MM
Stockholders Equity $76,804.00MM $68,774.00MM $71,490.00MM
Inventory $10,268.00MM $11,181.00MM $12,444.00MM
Assets $187,378.00MM $167,558.00MM $180,104.00MM
Operating Cash Flow $21,194.00MM $22,791.00MM $24,266.00MM
Capital expenditure $4,009.00MM $4,543.00MM $4,424.00MM
Investing Cash Flow $-12,371.00MM $878.00MM $-18,599.00MM
Financing Cash Flow $-8,871.00MM $-15,825.00MM $-3,132.00MM
Earnings Per Share** $7.47 $22.49 $5.84

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.